Volume 14, Issue 5 (5-2016)                   IJRM 2016, 14(5): 309-316 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azargoon A, Ghorbani R, Aslebahar F. Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study. IJRM 2016; 14 (5) :309-316
URL: http://ijrm.ir/article-1-751-en.html
Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study
Azam Azargoon * 1, Raheb Ghorbani2 , Fereshteh Aslebahar3
1- Abnormal Uterine Bleeding Research Center, Semnan University of Medical Sciences, Semnan, Iran , azarmona2003@yahoo.com
2- Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
3- Abnormal Uterine Bleeding Research Center, Semnan University of Medical Sciences, Semnan, Iran
Abstract:   (2892 Views)
Background: Preterm birth is the major cause of neonatal mortality and morbidity.
Objective: The aim of this study was to evaluate the effect of prophylactic vaginal progesterone on decreasing preterm birth rate and neonatal complications in a high-risk population.
Materials and Methods: A randomized, double-blind, placebo-controlled study was performed on 100 high-risk singleton pregnancies. Vaginal suppository progesterone (400 mg) or placebo was administered daily between 16-22 wks to 36 wks of gestation. Progesterone (n=50) and placebo (n=50) groups were compared for incidence of preterm delivery and neonatal complications.
Results: The preterm birth rate was 52%. Preterm birth rate before the 37 wks of gestation (68% vs. 36%: RR=1.89, 95% CI: 1.25-2.86) and also before the 34 wks of gestation (42% vs. 18%: RR=2.33, 95% CI: 1.19-4.58) in placebo group was significantly higher than progesterone group. Our study also showed that the administration of vaginal progesterone was associated with a significant reduction in the risk of birth weight ≤2500 gr, the rates of respiratory distress syndrome (RDS) and admission to the Neonatal Intensive Care Unit (NICU) in the progesterone group when compared with the placebo group. However, there was no significant difference between the two groups in terms of neonatal death, days of admission in NICU, intraventricular hemorrhage and necrotizing enterocolitis.
Conclusion: Prophylactic vaginal progesterone reduced the rate of preterm delivery, the risk of a birth weight ≤2500 gr, the rates of RDS and admission to NICU in women who were at risk of preterm delivery.
Keywords: Premature birth, Prevention, Progesterone, Randomized controlled trial
Full-Text [PDF 188 kb]   (797 Downloads) |   |   Full-Text (HTML)  (488 Views)  
Type of Study: Original Article |
References
1. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, editors. Williams Obstetrics. 24th Ed. New York: McGraw-Hill Medical; 2014.
2. Mathews J, McDonald MF. Infant mortality statistics from the 2008 period linked birth infant death data sct. Natl Vital Stat Rep 2012; 80: 1-49.
3. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2010. Natl Vital Stat Rep 2011; 60: 1-26
4. Martison DR, Damus K, Fiore E, Petrini J, Alter C. Preterm delivery: a public health perspective . Paediatr Perinat Epidemiol 2001; 15 (Suppl.): 7-16. [DOI:10.1046/j.1365-3016.2001.00004.x]
5. Gluckman PD, Hanson MA. Living with the past: evolution, development and patterns of disease. Science 2004; 305: 1733-1736. [DOI:10.1126/science.1095292]
6. Creasy RK. Preterm birth prevention: where are we? Am J Obstet Gynecol 1993; 168: 1223-1230. [DOI:10.1016/0002-9378(93)90373-Q]
7. American College of Obstetricians and Gynecologist (ACOG). Assessment of risk factors for preterm birth (ACOG Practice Bulletin NO. 31). Obstet Gynecol 2001; 98: 709-716. [DOI:10.1097/00006250-200110000-00035]
8. Papiernik E. [Double blind study of an agent to prevent pre-term delivery among women at increased risk]. In: Edition Schering; Serie4, fiche3: 1970: 65-68 (In French)
9. Keirse MJNC. Progestron administration in pregnancy may prevent preterm delivery. BR J Obstet Gynecol 1990; 97: 149-154. [DOI:10.1111/j.1471-0528.1990.tb01740.x]
10. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyl progestron caproate. N Engl J Med 2003; 348: 2379-2385. [DOI:10.1056/NEJMoa035140]
11. Mackenzie R, Walker M, Armson A, Hannah ME. Progestrone for the prevention of preterm birth among women at increased risk: A systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2006; 194: 1234-1242. [DOI:10.1016/j.ajog.2005.06.049]
12. da Fonsceca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progestron by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419-424. [DOI:10.1067/mob.2003.41]
13. Rouse DJ, Caitis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, et al. A trial of 17 alphahydroxyl progestron caproate to prevent prematurity in twins. N Engl Med 2007; 357: 454-461. [DOI:10.1056/NEJMoa070641]
14. O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, et al. progestron vaginal gel for the reduction of recurrent preterm birth : Primary results from a randomized, double blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007; 30: 687-696. [DOI:10.1002/uog.5158]
15. Tita AT, Rouse DJ. Progesterone for preterm birth prevention: An evolving intervention. Am J Obstet Gynecol 2009; 200: 219-224 [DOI:10.1016/j.ajog.2008.12.035]
16. Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev 2013; 7: CD004947. [DOI:10.1002/14651858.CD004947.pub3]
17. Berghella V, Figueroa D, Szychowski JM, Owent J, Hankins GD, Lams JD, et al. 17-alpha-hydroxyl progesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet Gynecol 2010; 202: 351-356. [DOI:10.1016/j.ajog.2010.02.019]
18. Grobman WA, ThomE, Spong CY, Lams JD, Soade GR, Mercer BM, et al. 17 alpha-hydroxyl progesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol 2012; 207: 390-398. [DOI:10.1016/j.ajog.2012.09.013]
19. De Franco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: A secondary analysis from a randomized , double blind , placebo- controlled trial. Ultrasound Obstet Gynecol 2007; 30: 697-705. [DOI:10.1002/uog.5159]
20. Cetingoz E, Cam C, Sakalli M, Karateke A, Celik C, Sancak A. Progesterone effects on preterm birth in high risk pregnancies: A randomized placebo-controlled trial. Arch Gynecol Obstet 2011; 283: 423-429. [DOI:10.1007/s00404-009-1351-2]
21. Sfakianaki AK, Norwitz ER. Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med 2006; 19: 763-772. [DOI:10.1080/14767050600949829]
22. Garfield RE, Kannan MS, Daniel EE. Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins. Am J Physiol 1980; 238: C81-C89. [DOI:10.1152/ajpcell.1980.238.3.C81]
23. Sfakianaki AK, Norwitz ER. Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med 2006; 19: 763-772. [DOI:10.1080/14767050600949829]
24. Challis JRG. Sharp increases in free circulating oestrogens immediately before parturition in sheep. Nature 1971; 229: 208. [DOI:10.1038/229208a0]
25. Mitchell B, Cruickshank B, McLean D, Challis J. Local modulation of progesterone production in human fetal membranes. J Clin Endocrinol Metab 1982; 55: 1237-1239. [DOI:10.1210/jcem-55-6-1237]
26. Frydman R, LeLaidier C, Baton-Saint-Mleux C, Fernandez H, Vial M, Bourget P. Labor induction in women at term with mifepristone(RU 486): a double-blind, randomized, placebo-controlled study. Obstet Gynecol 1992; 80: 972-975
27. Yellon SM, Burns AE, See JL, Lechuga TJ, Kirby MA. Progesterone withdrawal promotes remodeling processes in the nonpregnant mouse cervix. Biol Reprod 2009; 81: 16-85. [DOI:10.1095/biolreprod.108.074997]
28. Borna S, Sahabi N. Progesterone for maintenance tocolytic therapy after threatened preterm labor: A randomized controlled trial. Aust NZ J Obstet Gynecol 2008; 48: 58-63. [DOI:10.1111/j.1479-828X.2007.00803.x]
29. Khandelwal M. Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy. Int J Womens Health 2012; 4: 481-490. [DOI:10.2147/IJWH.S28944]
30. Berghella V, Rafael TJ, Szychowski JM, Rust OA, Owen J. Cerclage for Short Cervix on Ultrasonography in Women With Singleton Gestations and Previous reterm Birth: A Meta-Analysis. Obstet Gynecol 2011; 117: 663-671. [DOI:10.1097/AOG.0b013e31820ca847]
31. Hassan SS, Remero R, Vidyadhan D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: A multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38: 18-31. [DOI:10.1002/uog.9017]
32. Berghella V, Figueroa D, Szychowski JM, Owen J, Hankins GD, Iams JD, et al. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length. Am J Obstet Gynecol 2010; 202: 351. [DOI:10.1016/j.ajog.2010.02.019]
33. Alfirevic Z, Owen J, Carreras Moratonas E, Sharp An, Szychowski JM, Goya M. Vaginal progesterone , cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix. Ultrasound Obstet Gynecol 2013; 41: 146-151. [DOI:10.1002/uog.12300]
34. Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, Brien JM, Cetingoz E, et al. Vaginal progesterone VS cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth and singleton gestation: A systematic review and indirect comparison meta-analysis. Am J Obstet Gynecol 2013; 208: 42. [DOI:10.1016/j.ajog.2012.10.877]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb